FDA Drug Application (206426) for RAPIVAB by BIOCRYST

Back to FDA Applications sponsored by BIOCRYST

Application Number206426
Product Number001
FormSOLUTION;IV (INFUSION)
Dosage200MG/20ML (10MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRAPIVAB
Active IngredientPERAMIVIR



Back to FDA Applications sponsored by BIOCRYST